Ollin Biosciences

Redefining What's Possible in Ophthalmology

Austin, United States · Founded 2023 · $430.0M raised

Headquarters
Austin, Texas
Employees
11–50
Founded
2023
Business Model
B2B
Website
ollin.bio
Total Funding
$430.0M
Last Round
$330.0M Series BJun 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Ollin Biosciences is a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. Founded in 2023 and based in Austin, Texas, the company is advancing a pipeline of bispecific antibody programs including OLN324, a VEGF/Ang2 bispecific antibody in Phase 1b trials for wet AMD and diabetic macular edema, and OLN102 for thyroid eye disease.

Summary

Ollin Biosciences is a Biotech company based in Austin, United States, founded in 2023. It has raised $430.0M in total across 2 rounds, most recently a $330.0M Series B round in Jun 2026. Investors include ARCH Venture Partners, TCGX and Andreessen Horowitz.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BFunding RoundJun 2026
$330.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ollin Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/ollin-biosciences"><img src="https://indexed.vc/api/badge/company/ollin-biosciences" alt="Ollin Biosciences on Indexed.vc" width="260" height="76" /></a>